Company Directory
PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!
As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.
To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing for only £500/year, this offers even greater scope for added content (more photos, more links, more copy), and even more exposure.
Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.
By transforming recent scientific breakthroughs in axonal degeneration and neuroimmune regulation into neuroprotective medicines, we aim to offer renewed hope for those affected by serious neurological diseases.
Nurix is committed to bringing novel, first-in-class therapies to patients without adequate treatment options. Our small molecule drugs are designed to modulate protein levels in cells as a new therapeutic approach for a broad range of diseases.
A biopharmaceutical company developing next-generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. Our goal is to develop first in class drug candidates that prevent the disease instead of controlling it, and we achieve this through our collaboration with pioneer scientists in the field.
OMass is an Oxford University spin-out backed by Syncona Ltd and Oxford Sciences Innovation that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease.
ONK Therapeutics is dedicated to optimizing a next generation of off-the-shelf, dual-targeted NK cell therapies for patients with hematological malignancies and solid tumors.
OPRA specialise in offering tailored recruitment and search services. We work with clients throughout the UK on permanent, temporary and contract recruitment, encompassing job roles which require different levels of experience and expertise.
OSP Healthcare is an independent creative medical communications agency with a global reach. Having delivered more than 1000 projects in almost three decades for health-focused companies and organisations, our code-compliant team is well versed when it comes to the healthcare, pharma and biotech sectors.
OXGENE™ finds solutions to seemingly impossible problems. Our unique combination of precision engineering and breakthrough science, together with advanced robotics and bioinformatics, accelerates the rational design, discovery and manufacture of cell and gene therapies.
At Obsidian, we are pioneering engineered cell and gene therapies to deliver transformative outcomes for patients.
ObvioHealth is a Virtual Research Organization (VRO) leading the long overdue digitization of health innovation. We launched in 2017, leveraging technological innovation to tackle the inefficiencies in the trial process. But we knew then and now, that success would come from the fusion of experienced clinical researchers and pioneering health technologists.
Ochre Health is a network of health professionals who share a clear purpose and take a proactive approach in creating healthier communities. Together we can transform healthcare, giving you the infrastructure, support, tools and clinical autonomy needed to practice patient-centred care.
Family owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year. We focus on three therapeutic areas: haematology, immunotherapy and critical care.
At Omega Therapeutics, we are pioneering the discovery of epigenomic targets to develop a new class of therapeutics to fundamentally transform human medicine in the service of patients. Our objective is to become the leading digital and data-driven epigenetic medicines company.
Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, immunologic diseases (e.g., complement-mediated diseases and cancers) and central nervous system disorders.
Omizzur is a company specializing in peptide synthesis which provides high-quality peptide products to generic peptide R&D institutions worldwide. products include: exenatide, calcitonin, semaglutide, octreotide. Contact Omizzur Peptide for details.
Optares helps companies recruit highly-qualified senior and mid-level managers. Founded in Oldenburg in north-western Germany in 2003, our staff of 30 consultants recruits top people for companies throughout Germany. Our clients range from start-ups and family-run firms through mid-size businesses to global players.
OptiPharm Medical is a US-based company that specializes in pharmaceutical medicine, providing promotional and medical review as well as medical affairs and clinical trials support to the life sciences industry. We deliver the skills and capabilities of big sized agencies with the agility and nimbleness of a small agency.
Orchard was founded in 2015 — but our roots run deeper, going back to some of the first research and clinical development involving ex vivo autologous gene therapy. We’re proud that our scientists have played a central role in the evolution of this technology from a bold vision to a potentially life-transforming reality.
